CBD Life Sciences Inc (PK) (CBDL) Quote

None of it matters. The dilution once again will drive this back to .0001. Same as last two r/s. Wake up. They make more selling shares to suckers. Look at the price. After all the r/s no one is up.

🌿 Exciting news from CBD Life Sciences, Inc. $CBDL🌿

CBDL has just unveiled a groundbreaking nutritional supplement infused with mushroom extracts! 🍄 This innovative product is set to revolutionize the wellness space, combining the benefits of CBD with the power of mushrooms. With increasing demand for natural health solutions, this could be a major revenue driver for the company and position $CBDL as a leader in holistic wellness.

The future looks bright for both the company and its shareholders! 💥

#CBDL #WellnessRevolution #Innovation #CBD #NutritionalSupplements #RevenueGrowth

I never lost a dime here. Only reason I post. I had on a watch list for years. When I see these crooks doing the same after another r/s again. NO reason not to post it is same as before.

Nah Im ok took my losses and moved on :)

Wrong you are a bag holder not me. This is is doing the same as after last two r/s. Keep buying you must like being a bag holder.

$CBDL Unveils Groundbreaking Nutritional Supplement Infused With Mushroom Extracts, Set to Drive Revenue and Revolutionize Wellness
Projected to increase company revenue by 20% in the first year, capitalizing on the booming $18 billion wellness market.

SCOTTSDALE, AZ / ACCESSWIRE / September 17, 2024 / CBD Life Sciences, Inc. (CBDL), an innovative leader in the CBD wellness industry, is set to launch a cutting-edge nutritional supplement powder designed to harness the powerful health benefits of natural ingredients. This new supplement contains a proprietary blend of reishi mushroom extract, lion's mane mushroom extract, and ashwagandha root extract, offering an integrated approach to wellness by reducing stress, supporting brain health, and enhancing the immune system.

https://finance.yahoo.com/news/cbd-life-sciences-inc-unveils-120000245.html

Sometimes they never moved on I was bagholding with him when they buried us with the r/s ROFL hes still here whining

$CBDL Barchart https://www.barchart.com/stocks/quotes/CBDL/opinion

News; CBDL Projected to increase company revenue by 20% in the first year, capitalizing on the booming $18 billion wellness market.

SCOTTSDALE, AZ / ACCESSWIRE / September 17, 2024 / CBD Life Sciences, Inc. (CBDL), an innovative leader in the CBD wellness industry, is set to launch a cutting-edge nutritional supplement powder designed to harness the powerful health benefits of natural ingredients. This new supplement contains a proprietary blend of reishi mushroom extract, lion's mane mushroom extract, and ashwagandha root extract, offering an integrated approach to wellness by reducing stress, supporting brain health, and enhancing the immune system.


Recent studies highlight the effectiveness of reishi extract, not only in boosting the immune system but also in slowing or stopping tumor growth, a feature that positions this product as an essential addition to the wellness market. The blend of lion's mane extract and ashwagandha root provides additional cognitive support and anti-inflammatory benefits, making it an all-around solution for physical and mental well-being.

Unrivaled Benefits of Key Ingredients:

Reishi Mushroom Extract: Renowned for its immune-boosting and anti-cancer properties, research suggests it can slow tumor growth, making it one of the most potent natural supplements available today.

Lion's Mane Mushroom Extract: Known for supporting brain health, lion's mane helps to enhance cognitive function and promote nerve regeneration, ideal for those seeking long-term mental clarity.

Ashwagandha Root Extract: Widely celebrated for reducing stress and its anti-inflammatory effects, ashwagandha contributes to overall mental health and physical recovery.

Revenue Projections & Market Potential
With the global supplement market experiencing rapid growth, the introduction of this new product is projected to significantly boost CBD Life Sciences, Inc.'s annual revenue. Analysts expect the market for mushroom-infused supplements to reach $18 billion by 2028, and with the unique blend of ingredients in this product, CBD Life Sciences, Inc. is poised to capture a substantial portion of that market. This launch is expected to drive a revenue increase of 20% within the first year, positioning the company at the forefront of the wellness supplement industry.

A Vision for the Future
Lisa Nelson, President and CEO of CBD Life Sciences, Inc., stated, "We are incredibly excited to bring this innovative product to the market. With the growing demand for natural, scientifically backed health solutions, we believe this supplement will be a game-changer, not only for our company but for the health-conscious consumers we serve."

About CBD Life Sciences, Inc.
The CBD Vault Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. The CBD Vault has developed and is retailing/wholesale a full line of cannabidiol based & organic products including, Delta 8 & 10 Gummy's, Full Spectrum Tinctures & Gummy's, Pain Cream, Roll-on's, Salve, Full Pet Line, Pre-Rolls, Full Line of Spa Products, Sleep & Anxiety Edibles. The CBD Vault's products can be viewed and purchased on the Company's website www.thecbdvault.com.

Follow our social media for the latest updates!

X: https://www.x.com/CBDL_StockOTC

Instagram: https://www.instagram.com/cbd.vault

IR Contact: cbdvaultaz@gmail.com

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information

Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720

Contact Information

Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720

Related Images

SOURCE: CBD Life Sciences Inc.

$CBDL CBD Life Sciences, Inc. Unveils Groundbreaking Nutritional Supplement Infused With Mushroom Extracts, Set to Drive Revenue and Revolutionize Wellness

https://www.accesswire.com/918828/cbd-life-sciences-inc-unveils-groundbreaking-nutritional-supplement-infused-with-mushroom-extracts-set-to-drive-revenue-and-revolutionize-wellness

Projected to increase company revenue by 20% in the first year, capitalizing on the booming $18 billion wellness market.

SCOTTSDALE, AZ / ACCESSWIRE / September 17, 2024 / CBD Life Sciences, Inc. (CBDL), an innovative leader in the CBD wellness industry, is set to launch a cutting-edge nutritional supplement powder designed to harness the powerful health benefits of natural ingredients. This new supplement contains a proprietary blend of reishi mushroom extract, lion's mane mushroom extract, and ashwagandha root extract, offering an integrated approach to wellness by reducing stress, supporting brain health, and enhancing the immune system.

Recent studies highlight the effectiveness of reishi extract, not only in boosting the immune system but also in slowing or stopping tumor growth, a feature that positions this product as an essential addition to the wellness market. The blend of lion's mane extract and ashwagandha root provides additional cognitive support and anti-inflammatory benefits, making it an all-around solution for physical and mental well-being.

Unrivaled Benefits of Key Ingredients:

Reishi Mushroom Extract: Renowned for its immune-boosting and anti-cancer properties, research suggests it can slow tumor growth, making it one of the most potent natural supplements available today.

Lion's Mane Mushroom Extract: Known for supporting brain health, lion's mane helps to enhance cognitive function and promote nerve regeneration, ideal for those seeking long-term mental clarity.

Ashwagandha Root Extract: Widely celebrated for reducing stress and its anti-inflammatory effects, ashwagandha contributes to overall mental health and physical recovery.

Revenue Projections & Market Potential
With the global supplement market experiencing rapid growth, the introduction of this new product is projected to significantly boost CBD Life Sciences, Inc.'s annual revenue. Analysts expect the market for mushroom-infused supplements to reach $18 billion by 2028, and with the unique blend of ingredients in this product, CBD Life Sciences, Inc. is poised to capture a substantial portion of that market. This launch is expected to drive a revenue increase of 20% within the first year, positioning the company at the forefront of the wellness supplement industry.

A Vision for the Future
Lisa Nelson, President and CEO of CBD Life Sciences, Inc., stated, "We are incredibly excited to bring this innovative product to the market. With the growing demand for natural, scientifically backed health solutions, we believe this supplement will be a game-changer, not only for our company but for the health-conscious consumers we serve."

news https://www.accesswire.com/918828/cbd-life-sciences-inc-unveils-groundbreaking-nutritional-supplement-infused-with-mushroom-extracts-set-to-drive-revenue-and-revolutionize-wellness

1. Exciting developments with $CBDL! 🌿 Their recent MOU with a New York dispensary could lead to significant revenue growth and enhance shareholder value. The future looks bright for CBD Life Sciences! 💥 #CBDL #RevenueGrowth #CannabisIndustry

2. Loving the momentum behind $CBDL! With their strategic partnerships and innovative approach in the CBD market, they’re set to make a big impact. Great potential for both growth and value creation here! 🌟 #CBDL #Innovation #GrowthOpportunities

3. Fantastic news for $CBDL investors! Their latest moves in the CBD space are setting them up for exciting growth. The collaboration with a major dispensary in New York is a game changer. Cheers to future success! 🚀 #CBDL #Cannabis #StrategicPartnerships

What nonsense. This is the 3rd r/s. Non one is getting back any investment. Same as before it will end up diluted down to .0001. The management gets rich selling shares not CBD. They could never sell enough to just the trillions in dilution basis before 1st r/s. Keep buying they need to sell more shares.
.

https://x.com/CBDL_StockOTC/status/1835681036434325632

$CBDL Anyone buying the Regulation A will push this to get back the most for the investment. This will run for awhile before a drop. News likely from Lisa so likely to run.

$CBDL CBD Life Sciences, Inc. Expands Footprint With Proposed Strategic Acquisition of Interest in Two New York Cannabis Dispensaries
https://www.accesswire.com/907809/cbd-life-sciences-inc-expands-footprint-with-proposed-strategic-acquisition-of-interest-in-two-new-york-cannabis-dispensaries

LOL. Wrong. You will end up losing on this like others who thought that. Ignore the past her and lose your money. No one is up at these levels.

He’s clueless and doesn’t know how to trade and got bagged and posts here non stop everyday all he does is bash

You are posting just like others after each r/s. Same thing all over again. Like I said. Buys are filled by new shares. The price dropped after the r/s even faster this time. Last time posters would say same thing no dilution. Then we find out wrong it was billions. They are crooks. Yes you are blind if you do not get that fact. Stop supporting these crooks.

$CBDL Many personal attacks here. How blind am I? Dude all I’m saying is an order for them to move more shares. They need the price at least double where it is.

I remember after the last two r/s seeing same thing posted. Anyone holding this stock. Since the first r/s to this last one. All at a lost. Keep thinking they are not diluting. Only way to fill buys is new shares. This is same as before but you keep buying lol. These crooks get rich selling shares not product. The volume is drying up. They will keep dropping the price as needed to sell more shares. How blind are you to they are doing same thing again?

$CBDL No volume and that’s because the selling stopped. They can’t issue shares at this price.

They have not issued new shares in weeks. I get the updates notified if any changes. No new shares have been issued.

Any buying volume is filled by new shares. That is why it never runs up after since the 1st r/s. The management gets rich selling shares not products. That is why once again another r/s and more dilution. They will sell billions again. When doing the same thing. To think it will be different is wrong.

$CBDL I was only saying that news is due and it’ll probably uptick 2-3 ticks for an easy flip. A little volume comes in at a shoot up over 001.

Just stop. The dilution here will never end. How many r/s to get that? Any volume does not move it. New shares filling orders is why. Nothing has changed. This is just like after 1st two r/s. Buying this is throwing money away and making these crooks rich.

$CBDL No volume so must be none issued. Might take a run if no more shares are out. She is overdue for a press release.

$CBDL CBD Life Sciences, Inc. Expands Footprint With Proposed Strategic Acquisition of Interest in Two New York Cannabis Dispensaries
https://www.accesswire.com/907809/cbd-life-sciences-inc-expands-footprint-with-proposed-strategic-acquisition-of-interest-in-two-new-york-cannabis-dispensaries

This is same as after last few r/s. These crooks are looking for new suckers. So many said the same nonsense before last 2 r/s. Both times I said it would end up .0001 and it did. Noting new same rinse and repeat dilution. Keep buying they need suckers.

It was all over red the entire market relax

How is it looking. LOL. You really are clueless.

When this is at .0001 once again. Any buyers lose it all again. Scam.

I agree your are. Just like others before you. You post the same nonsense how things changed. Wrong.

Repetitive posts

Same old argument as after the last two r/s. They get rich selling shares not product. You keep buying and thinking otherwise. When again at .0001 you lose same as others have. This is the same nonsense as before. You are wrong the same as others.

We’re excited to announce that our LOI will be signed and finished soon for the Long Island dispensary location! One of our biggest accomplishments thus far!$CBDL— CBD Life Sciences Inc. $CBDL (@CBDL_StockOTC) September 5, 2024

If they start selling stock at .005 who cares that's a nice move pipe it down

All this needs is volume with the OS updating not increasing says alot

All dilution and why it will go back down to .0001 like before. Did not take long to go to these low prices. Buys are being filled by new shares issued. Wake up same as before.

I had not been for a while. Then I see they did another r/s and same nonsense posted like you are now.

NO a few posts to show the same nonsense posted by people all over again. Nothing changes here. Just another r/s and same dilution. Can't handle the truth huh?

Seems like this is your job

Why are you here then ? Been here for like 10 years

$CBDL Historical trades also the view - August to September chart -
https://finance.yahoo.com/quote/CBDL/history/

Keep ignoring that this is same as after last two r/s. Actually it went this low faster this time. NO matter what the volume is. The dilution is filling the buys. They will dilute billions again. It will end up at .0001 again. They get rich selling shares not CBA. Same dilution all over again. They can keep doing it. When so many new suckers buy them. Amazing how blind buyers are. Tell me how I am wrong. Heard same nonsense before last 2 r/s.

$CBDL chart view fundamental bounce break out target 0.002 imo

Significant Revenue Potential

Mellow Mornings represents a substantial revenue opportunity for CBD Life Sciences, Inc. With the nationwide growth of CBD coffee, the company projects that this new product could add up to $2 million in annual revenue within its first year of launch. This estimate is based on anticipated sales from both direct-to-consumer channels and partnerships with coffee shops and retailers across the country.

$CBDL Riding the Wave of a Growing Market

The CBD coffee market is experiencing rapid growth nationwide, with consumers increasingly seeking out wellness-oriented products that seamlessly integrate into their daily lives. Industry reports project the CBD-infused beverage market to reach $2.6 billion by 2025, driven by the rising popularity of functional beverages. Mellow Mornings is strategically positioned to capitalize on this trend, offering a unique product that combines the comforting ritual of coffee with the therapeutic benefits of CBD.

news https://www.otcmarkets.com/stock/CBDL/news/story?e&id=2970424

Gonna do well